Document Citation: 28 Pa. Code § 715.28

Header:
PENNSYLVANIA ADMINISTRATIVE CODE
Commonwealth of Pennsylvania
Pennsylvania Code
TITLE 28. HEALTH AND SAFETY
PART V. DRUG AND ALCOHOL FACILITIES AND SERVICES
CHAPTER 715. STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM


Date:
08/31/2009

Document:
§ 715.28. Unusual incidents

(a) A narcotic treatment program shall develop and implement policies and procedures to respond to the following unusual incidents:

(1) Physical assault by a patient.

(2) Inappropriate behavior by a patient causing disruption to the narcotic treatment program.

(3) Selling of drugs on the premises.

(4) Complaints of patient abuse (physical, verbal, sexual and emotional).

(5) Death or serious injury due to trauma, suicide, medication error or unusual circumstances.

(6) Significant disruption of services due to disaster such as fire, storm, flood or other occurrence.

(7) Incident with potential for negative community reaction or which the facility director believes may lead to community concern.

(8) Theft, burglary, break-in or similar incident at the facility.

(9) Drug related hospitalization of a patient.

(10) Other unusual incidents the narcotic treatment program believes should be documented.

(b) These policies and procedures shall include the following:

(1) Documentation of the unusual incident.

(2) Prompt review and investigation.

(3) Implementation of a timely and appropriate corrective action plan, when indicated.

(4) Ongoing monitoring of the corrective action plan.

(c) A narcotic treatment program shall file a written Unusual Incident Report with the Department within 48 hours following an unusual incident including the following:

(1) Complaints of patient abuse (physical, verbal, sexual and emotional).

(2) Death or serious injury due to trauma, suicide, medication error or unusual circumstances.

(3) Significant disruption of services due to a disaster such as a fire, storm, flood or other occurrence.

(4) Incidents with potential for negative community reaction or which the facility director believes may lead to community concern.

(5) Drug related hospitalization of a patient.